When compared with the individuals in the healthy group, the expression of CXCR2, PTPRC, CCR2, MNDA, NCF2, S100A9, S100A8, and S100A12 was also upregulated in NAFLD patients. The gene discussed is NCF2; the disease is metabolic dysfunction-associated steatotic liver disease.